Cargando…
Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
The primary cardiotoxic action of doxorubicin when used as antitumor drug is attributed to the generation of reactive oxygen species (ROS) therefore effective cardioprotection therapies are needed. In this sense, the antianginal drug nicorandil has been shown to be effective in cardioprotection from...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330507/ https://www.ncbi.nlm.nih.gov/pubmed/28245258 http://dx.doi.org/10.1371/journal.pone.0172803 |
_version_ | 1782511249639079936 |
---|---|
author | Asensio-López, Mari C. Soler, Fernando Pascual-Figal, Domingo Fernández-Belda, Francisco Lax, Antonio |
author_facet | Asensio-López, Mari C. Soler, Fernando Pascual-Figal, Domingo Fernández-Belda, Francisco Lax, Antonio |
author_sort | Asensio-López, Mari C. |
collection | PubMed |
description | The primary cardiotoxic action of doxorubicin when used as antitumor drug is attributed to the generation of reactive oxygen species (ROS) therefore effective cardioprotection therapies are needed. In this sense, the antianginal drug nicorandil has been shown to be effective in cardioprotection from ischemic conditions but the underlying molecular mechanism to cope with doxorubicin-induced ROS is unclear. Our in vitro study using the HL-1 cardiomyocyte cell line derived from mouse atria reveals that the endogenous nitric oxide (NO) production was stimulated by nicorandil and arrested by NO synthase inhibition. Moreover, while the NO synthase activity was inhibited by doxorubicin-induced ROS, the NO synthase inhibition did not affect doxorubicin-induced ROS. The inhibition of NO synthase activity by doxorubicin was totally prevented by preincubation with nicorandil. Nicorandil also concentration-dependently (10 to 100 μM) decreased doxorubicin-induced ROS and the effect was antagonized by 5-hydroxydecanoate. The inhibition profile of doxorubicin-induced ROS by nicorandil was unaltered when an L-arginine derivative or a protein kinase G inhibitor was present. Preincubation with pinacidil mimicked the effect of nicorandil and the protection was eliminated by glibenclamide. Quantitative colocalization of fluorescence indicated that the mitochondrion was the target organelle of nicorandil and the observed response was a decrease in the mitochondrial inner membrane potential. Interference with H(+) movement across the mitochondrial inner membrane, leading to depolarization, also protected from doxorubicin-induced ROS. The data indicate that activation of the mitochondrial ATP-sensitive K(+) channel by nicorandil causing mitochondrial depolarization, without participation of the NO donor activity, was responsible for inhibition of the mitochondrial NADPH oxidase that is the main contributor to ROS production in cardiomyocytes. Impairment of the cytosolic Ca(2+) signal induced by caffeine and the increase in lipid peroxidation, both of which are indicators of doxorubicin-induced oxidative stress, were also prevented by nicorandil. |
format | Online Article Text |
id | pubmed-5330507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53305072017-03-09 Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes Asensio-López, Mari C. Soler, Fernando Pascual-Figal, Domingo Fernández-Belda, Francisco Lax, Antonio PLoS One Research Article The primary cardiotoxic action of doxorubicin when used as antitumor drug is attributed to the generation of reactive oxygen species (ROS) therefore effective cardioprotection therapies are needed. In this sense, the antianginal drug nicorandil has been shown to be effective in cardioprotection from ischemic conditions but the underlying molecular mechanism to cope with doxorubicin-induced ROS is unclear. Our in vitro study using the HL-1 cardiomyocyte cell line derived from mouse atria reveals that the endogenous nitric oxide (NO) production was stimulated by nicorandil and arrested by NO synthase inhibition. Moreover, while the NO synthase activity was inhibited by doxorubicin-induced ROS, the NO synthase inhibition did not affect doxorubicin-induced ROS. The inhibition of NO synthase activity by doxorubicin was totally prevented by preincubation with nicorandil. Nicorandil also concentration-dependently (10 to 100 μM) decreased doxorubicin-induced ROS and the effect was antagonized by 5-hydroxydecanoate. The inhibition profile of doxorubicin-induced ROS by nicorandil was unaltered when an L-arginine derivative or a protein kinase G inhibitor was present. Preincubation with pinacidil mimicked the effect of nicorandil and the protection was eliminated by glibenclamide. Quantitative colocalization of fluorescence indicated that the mitochondrion was the target organelle of nicorandil and the observed response was a decrease in the mitochondrial inner membrane potential. Interference with H(+) movement across the mitochondrial inner membrane, leading to depolarization, also protected from doxorubicin-induced ROS. The data indicate that activation of the mitochondrial ATP-sensitive K(+) channel by nicorandil causing mitochondrial depolarization, without participation of the NO donor activity, was responsible for inhibition of the mitochondrial NADPH oxidase that is the main contributor to ROS production in cardiomyocytes. Impairment of the cytosolic Ca(2+) signal induced by caffeine and the increase in lipid peroxidation, both of which are indicators of doxorubicin-induced oxidative stress, were also prevented by nicorandil. Public Library of Science 2017-02-28 /pmc/articles/PMC5330507/ /pubmed/28245258 http://dx.doi.org/10.1371/journal.pone.0172803 Text en © 2017 Asensio-López et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Asensio-López, Mari C. Soler, Fernando Pascual-Figal, Domingo Fernández-Belda, Francisco Lax, Antonio Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title_full | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title_fullStr | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title_full_unstemmed | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title_short | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
title_sort | doxorubicin-induced oxidative stress: the protective effect of nicorandil on hl-1 cardiomyocytes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330507/ https://www.ncbi.nlm.nih.gov/pubmed/28245258 http://dx.doi.org/10.1371/journal.pone.0172803 |
work_keys_str_mv | AT asensiolopezmaric doxorubicininducedoxidativestresstheprotectiveeffectofnicorandilonhl1cardiomyocytes AT solerfernando doxorubicininducedoxidativestresstheprotectiveeffectofnicorandilonhl1cardiomyocytes AT pascualfigaldomingo doxorubicininducedoxidativestresstheprotectiveeffectofnicorandilonhl1cardiomyocytes AT fernandezbeldafrancisco doxorubicininducedoxidativestresstheprotectiveeffectofnicorandilonhl1cardiomyocytes AT laxantonio doxorubicininducedoxidativestresstheprotectiveeffectofnicorandilonhl1cardiomyocytes |